Maxwell Biomedical announced that it has initiated its First-In-Human Clinical Trial “Initial Experience with Spatial Resynchronization Therapy in Patients with Atrial Fibrillation (SR-TheAF)” continue reading the article here.
Rhythm
Cardiac Insight Comments on CMS Plans to Establish Nationwide Payment for Long-Term ECG Monitoring in 2023
U.S. based cardiac arrhythmia diagnostic medical device system innovator supports CMS Proposed National Payment Framework for Long-Term ECG Monitoring BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, shares its perspective on recent announcements […]
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy
Research collaboration with the University of Utah’s Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for multiple genetic segments of arrhythmogenic cardiomyopathy CAMBRIDGE, Mass.–(BUSINESS WIRE)–Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve […]
FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics
First and only machine learning algorithm to assist healthcare professionals in identifying structural heart murmurs using a smart stethoscope OAKLAND, Calif., July 12, 2022 /PRNewswire/ — Eko, a digital health company advancing heart and lung disease detection, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Eko Murmur Analysis […]
CVRx Launches a new Barostim™ Programmer
The new Barostim Programmer launches in the U.S., making Barostim therapy programming simpler and enabling remote view access to enhance customer support MINNEAPOLIS, July 12, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has launched […]
Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter
ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark submission for its MAGiC™ catheter. The MAGiC catheter is a robotically navigated magnetic interventional ablation catheter for minimally invasive cardiac ablation procedures. Used […]
BIOTRONIK’s State-of-the-Art LiveSupport Successfully Used in BIOMONITOR Implantable Cardiac Monitor Implants
LAKE OSWEGO, Ore., July 6, 2022 /PRNewswire/ — BIOTRONIK’s state-of-the-art LiveSupport feature was used to remotely support two BIOMONITOR Implantable Cardiac Monitor (ICM) implants shortly after launch. Both procedures were performed with a BIOTRONIK representative in a remote location. The physicians are pleased with the results and the support offered; they are […]
Anumana Announces Issuance of New American Medical Association CPT® Category III Codes for Novel ECG AI Analysis of Cardiac Dysfunction
Ground-breaking codes will facilitate the use, adoption, and pathway for potential reimbursement of AI-enhanced ECG-based algorithms, including Anumana’s pipeline of AI-enhanced ECG-based algorithms CAMBRIDGE, Mass.–(BUSINESS WIRE)–Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced the American Medical Association (AMA) has issued new industry-first Category III Current Procedural Terminology (CPT®) codes […]
LIVEMETRIC RECEIVES FDA CLEARANCE FOR ITS WATCH-LIKE WEARABLE BLOOD PRESSURE MONITORING TECHNOLOGY, A LONG-AWAITED REVOLUTION IN CUFF-FREE HYPERTENSION MONITORING
LiveMetric is launching LiveOne, an FDA-cleared wearable technology for health systems, health insurers, and self-insured employers to improve the care and treatment of people with hypertension and cardiovascular disease. DENVER and LUXEMBOURG, June 30, 2022 /PRNewswire/ — LiveMetric, a leader in medical wearable technology, today announced the launch of LiveOne, the world’s first 510(k) U.S. Food and Drug Administration […]
HeartBeam Expands Patient Population for Emergency Department Software Technology Solution
Expanded Scope of Clinical Validation Study Will Provide Access to a Broader Patient Population Company Expects to File 510K No Later Than August 15, 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today […]
Recent
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
Popular
- No commented posts yet